Hepatitis/HIV Clinical Trials Group (HHCTG)

San Francisco, California 94110

0 studies enrolling now · 1 studies all time

What they study most

HIV-1-infection

Studies at this site

• Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed — Completed